ADMA Biologics, Inc.
ADMA
$20.43
$0.794.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 111.90M | 35.91M | 32.06M | 17.81M | -17.65M |
| Total Depreciation and Amortization | 1.94M | 1.94M | 2.05M | 2.11M | 2.11M |
| Total Amortization of Deferred Charges | 219.00K | 252.00K | 227.00K | 253.00K | 698.00K |
| Total Other Non-Cash Items | -77.57M | 3.15M | 2.83M | 2.13M | 28.83M |
| Change in Net Operating Assets | 13.72M | -16.22M | 8.48M | -24.52M | 3.60M |
| Cash from Operations | 50.22M | 25.03M | 45.65M | -2.22M | 17.60M |
| Capital Expenditure | -2.76M | -1.06M | -2.07M | -2.35M | -1.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.00K | -42.00K | -299.00K | -15.00K | -210.00K |
| Cash from Investing | -2.75M | -1.10M | -2.37M | -2.36M | -1.41M |
| Total Debt Issued | -- | -- | -- | -- | 135.00M |
| Total Debt Repaid | -30.00M | -30.00M | -- | -- | -158.59M |
| Issuance of Common Stock | 443.00K | 5.69M | 331.00K | 1.03M | 8.00K |
| Repurchase of Common Stock | -644.00K | -1.16M | -693.00K | -2.48M | -341.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -825.00K | -- | -- | -- | -15.08M |
| Cash from Financing | -31.03M | -25.47M | -362.00K | -1.45M | -39.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.44M | -1.54M | 42.92M | -6.03M | -22.81M |